LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
The latest regulatory, legal, compliance, and technology news for labs and pathology practices.
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
By Mike O'Brien...
By Dan Scungio...
If employers want to build a future-ready organization, they need to chart a new playbook for how work happens.
In the latest...
By Mike O'Brien...
By Mike O’Brien...